PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | C0155773|portal vein thrombosis |
| Sentences | 26 |
| PubMedID- 23000237 | Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. |
| PubMedID- 22330617 | Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report. |
| PubMedID- 25584161 | Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival. |
| PubMedID- 22689916 | It is a safe and effective treatment prolonging the survival of hepatocellular carcinoma patients with portal vein thrombosis. |
| PubMedID- 24740759 | Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 25088384 | Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis. |
| PubMedID- 22237844 | hepatocellular carcinoma patient with main portal vein thrombosis. |
| PubMedID- 21054520 | Background and aim: we aimed to validate the non-invasive criteria for the characterization of portal vein thrombosis (pvt) in patients with cirrhosis and hepatocellular carcinoma (hcc). |
| PubMedID- 20981227 | Treatment of hepatocellular carcinoma with portal vein thrombosis by sorafenib combined with hepatic arterial infusion chemotherapy. |
| PubMedID- 21224554 | We herein report a case of advanced hepatocellular carcinoma (hcc) with vp4 portal vein thrombosis (pvtt). |
| PubMedID- 25834310 | Management of hepatocellular carcinoma (hcc) with portal vein thrombosis (pvt) is complex and requires an understanding of multiple therapeutic options. |
| PubMedID- 21033233 | The efficacy of combined transarterial chemoembolization and 3-dimensional conformal radiotherapy for hepatocellular carcinoma with main portal vein thrombosis. |
| PubMedID- 26157747 | New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 25847227 | Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 21076591 | This simplified method demonstrates excellent technical feasibility, an acceptable range of complications, and is hence recommended for the management of advanced hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 21190093 | Introduction: portal vein thrombosis is frequently associated with hepatocellular carcinoma (hcc). |
| PubMedID- 23476792 | Treating lobar hepatocellular carcinoma with ipsilateral portal vein thrombosis with yttrium-90 glass-microsphere radioembolization is safe and efficacious. |
| PubMedID- 21659784 | Long-term outcome of combined interferon-alpha and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis. |
| PubMedID- 21443089 | Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis. |
| PubMedID- 23914640 | Conclusion: colour doppler sonognaphy is an effective, non-invasive method for evaluating the presence of portal vein thrombosis associated with hepatocellular carcinoma. |
| PubMedID- 23914915 | Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib. |
| PubMedID- 25502254 | Eus-fna of a portal vein thrombosis in a patient with a hidden hepatocellular carcinoma: confirmation technique after contrast-enhanced ultrasound. |
| PubMedID- 26133576 | Is radioembolization ((90)y) better than doxorubicin drug eluting beads (debdox) for hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 22563286 | Ct scanning is very helpful for identifying the presence and type of gv, to assess gv outflow direction, such as a gastro-renal shunt, to assess the risk of systemic embolization by evo, to identify the presence of hepatocellular carcinoma with or without portal vein thrombosis, and to evaluate the applicability of salvage treatments, such as tips or brto, in cases of evo failure. |
| PubMedID- 22206054 | Atypical enhancement pattern of hepatocellular carcinoma with portal vein thrombosis on multiphasic ct. |
| PubMedID- 21796552 | We aimed to evaluate the magnetic resonance imaging findings of widespread hepatocellular carcinoma lesions complicated with portal vein thrombosis. |
Page: 1